Hematologic complications in patients exposed to poly-ADP ribose polymerase inhibitors

Key Points

• This research seeks to identify the hematologic complications associated with poly-ADP ribose polymerase inhibitors.
• Clinical observations in patients exposed to poly-ADP ribose polymerase inhibitors
• Analysis of hematologic parameters including blood counts and clotting factors
• Assessment of immune response alterations
• Increased incidence of anemia among patients
• Elevated clotting factors leading to potential bleeding disorders
• Altered immune responses, suggesting higher infection risks